| Literature DB >> 30920391 |
Mohsen Khosravi-Maharlooei1, Aleksandar Obradovic1, Aditya Misra1, Keshav Motwani2, Markus Holzl1, Howard R Seay2, Susan DeWolf1, Grace Nauman1,3, Nichole Danzl1, Haowei Li1, Siu-Hong Ho1, Robert Winchester4, Yufeng Shen5, Todd M Brusko2, Megan Sykes1,3,6.
Abstract
We investigated human T-cell repertoire formation using high throughput TCRβ CDR3 sequencing in immunodeficient mice receiving human hematopoietic stem cells (HSCs) and human thymus grafts. Replicate humanized mice generated diverse and highly divergent repertoires. Repertoire narrowing and increased CDR3β sharing was observed during thymocyte selection. While hydrophobicity analysis implicated self-peptides in positive selection of the overall repertoire, positive selection favored shorter shared sequences that had reduced hydrophobicity at positions 6 and 7 of CDR3βs, suggesting weaker interactions with self-peptides than unshared sequences, possibly allowing escape from negative selection. Sharing was similar between autologous and allogeneic thymi and occurred between different cell subsets. Shared sequences were enriched for allo-crossreactive CDR3βs and for Type 1 diabetes-associated autoreactive CDR3βs. Single-cell TCR-sequencing showed increased sharing of CDR3αs compared to CDR3βs between mice. Our data collectively implicate preferential positive selection for shared human CDR3βs that are highly cross-reactive. While previous studies suggested a role for recombination bias in producing "public" sequences in mice, our study is the first to demonstrate a role for thymic selection. Our results implicate positive selection for promiscuous TCRβ sequences that likely evade negative selection, due to their low affinity for self-ligands, in the abundance of "public" human TCRβ sequences.Entities:
Keywords: Autoimmunity; Immunology; T cell development; T-cell receptor; Tolerance
Mesh:
Substances:
Year: 2019 PMID: 30920391 PMCID: PMC6546456 DOI: 10.1172/JCI124358
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 19.456